Western blot shows lysates of mouse liver tissue. PVDF membrane was probed with 1 µg/mL of Goat Anti-Mouse Kremen‑1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1647) followed by HRP-conjugated ...read more
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Immunogen affinity purified
Reconstitute at 0.2 mg/mL in sterile PBS.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Kremen-1 Antibody
kremen protein 1
kringle containing transmembrane protein 1
kringle containing transmembrane protein
Kringle domain-containing transmembrane protein 1
kringle-coding gene marking the eye and the nose
Kringle-containing protein marking the eye and the nose
Kremen (Kringle-containing protein marking the eye and the nose) proteins are type I transmembrane proteins that contain extracellular kringle, WSC and CUB domains and an intracellular region without any conserved motifs (1). Two related members, Kremen-1 and -2, have been identified. Kremens bind a subset of the secreted Dickkopf (Dkk) proteins (Dkk-1, -2, and -4) with high affinity to modulate the canonical Wnt signaling pathway that is transduced by the ternary receptor complex composed of Wnt, the seven-transmembrane domain receptor Frizzled, and the LDL-receptor-related protein 5/6 (LRP5/6) co-receptor (2, 3). Within the Dkk family, Dkk-1 and -4 bind directly to the LRP5/6 co-receptor to antagonize the canonical Wnt/ beta -catenin signaling pathway, but not the planar cell polarity (PCP) signaling pathway that does not involve LRP5/6 (4). In contrast, Dkk-3 has no effect on Wnt signaling and Dkk-2 can function either as an LRP agonist or antagonist, depending on whether the cell expresses Kremen (5). Kremen co-operates with Dkk to antagonize Wnt signaling via formation of a Kremen-Dkk-LRP ternary complex that triggers the internalization and clearance of the complex from the cell surface (3). All three extracellular domains but not the cytoplasmic region of a membrane anchored Kremen are needed for binding to the second cysteine-rich domain of Dkks (3). Mouse Kremen-1 cDNA encodes a 473 amino acid (aa) glycosylated protein with a putative 19 aa signal peptide, a 372 aa extracellular domain, a 21 aa transmembrane domain and a 60 aa cytoplasmic domain. In the extracellular domain, it shares 92% and 41% amino acid sequence identity with human Kremen-1 and mouse Kremen-2, respectively. Mouse Kremen-1 is widely expressed in diverse embryonic (apical ectodermal ridge of the developing fore- and hindlimb buds, telencephalon and the first brachial arch, myotome and sensory tissues) and adult (lung, heart, kidney, skeletal muscle and testis) tissues (1).
Nakamura, T. et al. (2001) Biochim Biophys Acta 1518:63.
Davidson G. et al. (2002) Development 129:5587.
Mao, B. et al. (2002) Nature 417:664.
Zorn, A.M. (2001) Curr. Biol. 11:R592.
Mao, B. and C. Niehrs (2003) Gene 302:179.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our Kremen-1 Antibody and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.